本文へ移動
cccskills
無料GitHub で公開

es-cushing-medical-therapy-block-aberrant-receptors-bmah

This skill suggests medical therapy to block aberrant hormone receptors for bilateral macronodular adrenal hyperplasia (BMAH) when surgery is not preferred or feasible. Consider this approach in patients with confirmed BMAH and evidence of aberrant hormone receptor expression (e.g., GIP, LH/hCG, serotonin) driving cortisol excess.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.6 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Medical Therapy to Block Aberrant Hormone Receptors for Bilateral Macronodular Adrenal Hyperplasia

STEP 1 — Gather Information

Confirm BMAH diagnosis with bilateral adrenal nodules on CT/MRI and hormonal evidence of autonomous cortisol secretion (elevated UFC, non‑suppressible cortisol). Assess patient preference and surgical feasibility. Perform adrenal vein sampling or hormone challenge tests (meal, GIP, LH/hCG, serotonin) to identify aberrant hormone receptors driving cortisol excess.

STEP 2 — Rule In / Rule Out

Rule in aberrant hormone receptor expression if hormone challenge provokes a cortisol rise >20% or adrenal vein sampling shows receptor‑linked secretion; rule out if no such reactivity is detected.

STEP 3 — Classify or Stratify

Classify the aberrant receptor type (e.g., GIP receptor, LH/hCG receptor, serotonin receptor, adrenal androgen receptor) to guide selection of specific antagonist therapy.

STEP 4 — Decide

Initiate medical therapy targeting the identified aberrant receptor (e.g., ketoconazole or metyrapone for steroidogenesis inhibition, or receptor‑specific antagonists such as cyproheptadine for serotonin, GnRH antagonist for LH/hCG, or investigational GIP antagonist) with the goal of normalizing cortisol levels.

Clinical Guardrails / Mimics / Pitfalls

Do not use receptor‑blocking therapy when surgery is feasible and preferred; avoid in patients with known hypersensitivity to the chosen agent; monitor for adrenal insufficiency and hypocortisolism; do not rely solely on receptor blockade if cortisol remains elevated, as adjunctive steroidogenesis inhibition may be needed; avoid agents that stimulate cortisol secretion (e.g., exogenous ACTH).

Concrete Clinical Example

A 48‑year‑old woman with bilateral adrenal nodules on CT, unsuppressed cortisol, declines surgery due to cardiac risk. Adrenal vein sampling after oral GIP shows a 45% cortisol rise, indicating aberrant GIP receptor. She is started on ketoconazole 400 mg twice daily; after 3 weeks UFC falls to normal range and symptoms improve.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI: 10.1210/jc.2015-1818

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する